Your browser doesn't support javascript.
loading
Control of diabetic hyperglycaemia and insulin resistance through TSC22D4.
Ekim Üstünel, Bilgen; Friedrich, Kilian; Maida, Adriano; Wang, Xiaoyue; Krones-Herzig, Anja; Seibert, Oksana; Sommerfeld, Anke; Jones, Allan; Sijmonsma, Tjeerd P; Sticht, Carsten; Gretz, Norbert; Fleming, Thomas; Nawroth, Peter P; Stremmel, Wolfgang; Rose, Adam J; Berriel-Diaz, Mauricio; Blüher, Matthias; Herzig, Stephan.
  • Ekim Üstünel B; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Friedrich K; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Maida A; Department of Internal Medicine IV, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Wang X; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Krones-Herzig A; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Seibert O; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Sommerfeld A; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Jones A; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Sijmonsma TP; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Sticht C; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Gretz N; Center for Clinical Research, Medical Faculty Mannheim, 68167 Mannheim, Germany.
  • Fleming T; Center for Clinical Research, Medical Faculty Mannheim, 68167 Mannheim, Germany.
  • Nawroth PP; Department of Medicine I and Clinical Chemistry, Heidelberg University, 69120 Heidelberg, Germany.
  • Stremmel W; Department of Medicine I and Clinical Chemistry, Heidelberg University, 69120 Heidelberg, Germany.
  • Rose AJ; Department of Internal Medicine IV, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Berriel-Diaz M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Blüher M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine I, 85764 Neuherberg, Germany.
  • Herzig S; Department of Medicine, University of Leipzig, 04103 Leipzig, Germany.
Nat Commun ; 7: 13267, 2016 11 09.
Article en En | MEDLINE | ID: mdl-27827363
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Glucemia / Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Glucemia / Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article